Navigation Links
Luminex Corporation Reports Second Quarter 2013 Results
Date:7/29/2013

throp, president and chief executive officer of Luminex. "In addition, we surpassed a major milestone for the Company in the second quarter, delivering our 10,000th multiplexing analyzer to date.  The entire company is proud of this achievement," added Balthrop.

"Notwithstanding our success during the second quarter, the overall molecular diagnostic market began to experience a deceleration in the utilization of certain molecular assays. This is a result of administrative issues related to the reimbursement of certain tests included in the new molecular diagnostic code system established January 1, 2013 by the Centers for Medicare and Medicaid Services. A number of our lab customers have expended significant efforts in striving for a rapid resolution, nonetheless progress has been slow. While the situation remains fluid, we believe it is prudent to adjust our expectations for the second half of 2013 to account for this headwind," Balthrop concluded. REVENUE SUMMARY(in thousands, except percentages)Three Months EndedJune 30,Variance20132012($)(%)(unaudited)System sales

$
7,647$   8,386$
(739)-9%Consumable sales

11,75010,8029489%Royalty revenue

8,5787,71586311%Assay revenue

21,69917,5104,18924%All other revenue

4,6133,86075320%$   54,287$ 48,273$   6,01412%Six Months EndedJune 30,Variance20132012($)(%)(unaudited)System sales

$   14,204$ 15,384$  (1,180)-8%Consumable sales

23,64722,7029454%Royalty revenue

18,68715,9572,73017%Assay revenue

40,02334,8075,21615%All other revenue

10,9268,1502,77634%$ 107,487$ 97,000$ 10,48711% 

"We are pleased with the overall financial performance in the second quarter of 2013, especially as we continue to invest in our strategic priorities," said Harriss T. Currie, senior vice president and chief financial officer. "The 18% increase in operating expenses for the second quarter reflects agg
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Reports First Quarter 2012 Results
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Reports Second Quarter 2012 Results
5. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
6. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
7. Luminex Corporation Recognized as Best Technology Company in Austin
8. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
9. Luminex Corporation To Present At Upcoming Investment Conferences In September
10. Luminex Corporation Reports Third Quarter 2012 Results
11. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. and BRUSSELS ... AMGN ) and UCB (Euronext Brussels: UCB) today ... evaluating effect of RomosozUmab Compared with Teriparatide in ... fracture pReviously treated with bisphosphonatE therapy). The study ... significant difference in favor of romosozumab in the ...
(Date:9/1/2015)... Sept. 1, 2015 Emerus Holdings, a ... emergent, inpatient and diagnostic care in partnership with ... a definitive agreement to receive a strategic investment ... a leading health care investment firm. ... patient-centric acute episodic and ambulatory clinical services to ...
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: ... emerging leader in the development, assembly, marketing and sale ... that the Company,s growing business earned a BBB+ Credit Rating ... "Zhongguancun Association") and was approved as a member of ...
... SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing company, ... results for the fourth quarter and full year ended ... host a conference call to discuss the results at ...
Cached Medicine Technology:Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 2Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 3ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012 2
(Date:9/1/2015)... Los Angeles, CA (PRWEB) , ... September 01, ... ... 26 on Dental Economics, the author explained how many dental practices across the ... Assisted Design/Computer Assisted Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical ... announce their partnership with Apex Physical Therapy (Apex) is official as ... provide kind, compassionate, and empathetic care to local residents from their combined eight ...
(Date:9/1/2015)... ... September 01, 2015 , ... Philanthropic giving in the U.S. has ... and needs. Money for Good 2015, released today by Camber Collective, goes to the ... potential to mobilize up to $22B in new philanthropic giving and shift $25B that’s ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... care delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) has ... 2016. , Based in San Francisco, Doctor On Demand provides immediate access ...
(Date:9/1/2015)... ... 2015 , ... OncLive® today announced it is ... World Report, to provide breaking news and information about the hospital’s pioneering research ... which provides oncologists resources and information?they need to deliver the best care for?their?patients, ...
Breaking Medicine News(10 mins):Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3
... from Asthma & Allergy Foundation of America JACKSONVILLE, Fla., ... as itchy, dry, red and watery eyes leave them ... new survey conducted by the Asthma & Allergy Foundation ... allergy sufferers surveyed say their red and puffy eyes ...
... pass companion resolution recognizing sacrifices made by nuclear weapons ... country during the Cold War DENVER, May 28 ... October 30, 2009, a national day of remembrance ... their country during the Cold War Era. The ...
... In a bombshell exposé of California,s massive, unfunded public employee retirement ... cable systems featuring public pension fund officials and finance experts, including ... series is also available on DVD. Featured here is a ... ...
... employee survey solutions, 360 surveys and manager feedback surveys, announced today that ... the East Coast. , ... Chicago, IL (PRWEB) May 28, 2009 -- ... employee survey solutions , 360 surveys and manager feedback ...
... 2009 Immunology researchers at UT Southwestern Medical Center ... in promoting the development of a group of immune ... their initial response, these immune cells, known as cytotoxic ... They also provide long-term protection against pathogens by "remembering" ...
... May 27 Balfour Beatty Construction and Sleep ... the 2009 Greater Dallas Business Ethics Awards. Two ... and Frisco Medical Center, L.L.P., were among the ... Relocation, American Fuel Distributors, L.P., Aspire, Cadence McShane ...
Cached Medicine News:Health News:Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals 2Health News:Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals 3Health News:Senate Honors Nuclear and Uranium Workers With National Day of Remembrance 2Health News:California Public Pension Crisis: The Ticking Time Bomb, a Full Disclosure Network Cable TV Series 2Health News:Lightspeed Research - The Foresight Group, Announced Today that Holly Bossert has Joined the Company as a Senior Account Manager for the East Coast 2Health News:Immunologists identify biochemical signals that help immune cells remember how to fight infection 2Health News:Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards 2
... The SeedVac™ is a vacuum driven device designed to ... tube tip. Seeds are drawn into the clear tube ... the hand piece to create the vacuum. The prescribed ... the clear tube tip before being placed into the ...
MT-BT-5001-25 prostate seeding needle (set of 25 unloaded needles).,MT-BT-5001-P prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seeding...
... a myoma was performed with a cutting ... vaporization of myomas with the VaporTrode Vaporization ... tissue chips that obscure visibility. No tissue ... This unique design provides areas of high ...
... The 19 Fr. OES 4000 Nephroscope, with ... quality with outstanding durability. The lumbotome, for ... the telescopic bougies, allow safer access. The ... comprehensive range of grasping forceps and lithotripsy ...
Medicine Products: